Have You Seen BioPharm International's New and Improved Site Design?
» Visit www.biopharminternational.com to utilize our upgraded search engine, view expanded topic coverage, experience multimedia content, access content archives, and more.

BioPharm International is pleased to present its 2010 Web Seminar Series, addressing key issues in process development and bioprocessing. These one-hour sessions include presentations by industry experts and interactive dialogue with the audience. Watch live and participate in the Q&A, or catch them later on demand.

Analytical Strategies for Monitoring Residual Impurities Encountered In Bioprocessing
Profiling of impurities in biopharmaceuticals and their associated intermediates and excipients is a regulatory expectation. Since residuals are typically present at low levels in difficult sample matrices, development and validation of assays can be quite challenging. Due to the range of potential impurities, many different analytical strategies are needed.

In-Vivo Spectroscopy: Studies of Skin and Cartilage
Non-ivasive FTIR is used to study skin chemistry and identify diseased cartilage tissue.

Efficient Development of Peptide Maps using the ACQUITY UPLC H-Class System
The ACQUITY UPLC H-Class System is used for the systematic optimization of peptide mapping conditions in a fully automated protocol using four-solvent blending. The system's four-solvent blending capability enables the user to focus on the quality of the analysis so that reliable results can be obtained efficiently.

Featured Webcasts:

BIOPHARM INTERNATIONAL 2010 WEBCAST SERIES
BioPharm International is pleased to present its 2010 Web Seminar Series, addressing key issues in process development and bioprocessing. These one-hour sessions include presentations by industry experts and interactive dialogue with the audience. Watch live and participate in the Q&A, or catch them later on demand.

Tuesday, June 8, 2010 at 11:00 AM ET
Quality by Design in Biotech: Keys to Implementation
Applying the concepts of Quality by Design to the manufacture of biotech products involves some nuances and complexities. This web seminar will provide guidance for implementing QbD with biopharmaceuticals, including recommendations from the QbD Working Group of the PhRMA Biologics and Biotechnology Leadership Committee and industry case studies of applying QbD to various steps of process development for different unit operations.

Tuesday, September 21, 2010 at 11:00 AM ET
Addressing the Challenges of Downstream Processing, Today and Tomorrow
As upstream titers continue to improve, companies need solutions to ensure that cell culture gains are not lost in a downstream bottleneck. This web seminar will share data on new strategies and disruptive technologies that can streamline current processes and facilitate productivity, as well as improvements in traditional unit operations.

Thursday, November 11, 2010 at 11:00 AM ET
Characterizing Protein Products: Critical Questions and New Technologies
Protein characterization has always been critical for setting product specifications, determining process controls and release tests, and for establishing comparability after scale-up or site changes. Today, the analysis of protein structure has become even more important, given its key role in the debate over what constitutes “similarity” for biosimilar molecules. This seminar will analyze accepted and emerging methods for protein characterization, including the strengths and weaknesses of the methods and their use in regulatory filings.

UPLC, QT of, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science